BIP Meeting Center (Room ‘Salles des Guichets’), Rue Royale 2-4, 1000 Bruxelles
Resources:
BIP Meeting Center (Room ‘Salles des Guichets’), Rue Royale 2-4, 1000 Bruxelles
Consulting physician, Association of Austrian Social Insurance Institutions
Senior Adviser HTA, FIPRA RWE4Decisions Facilitator
Coordinating Advisor on Health, Permanent Representation of Spain to the European Union
Director of Digital, EU4Health and Health Systems Modernisation, DG SANTE, European Commission
Head of Real-World Evidence Workstream, European Medicines Agency
Board Member, World Duchenne Organisation
Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Senior Adviser HTA, FIPRA International RWE4Decisions Facilitator
Senior Researcher, Università Cattolica del Sacro Cuore Roma
Head of the Real-World Evidence Coordination Unit, Haute Autorité de Santé (HAS)
Former CEO, National Institute of Health and Disability Insurance, Belgium (INAMI-RIZIV)
Vice-President, Head of Patient Value & Access EUCAN, Global Pricing & Access, Takeda
Deputy CEO, National Institute of Health and Disability Insurance, Belgium (INAMI-RIZIV)
Chief Pharmacist, Swedish Dental and Pharmaceuticals Benefits Agency (TLV)
Oncologist, Genolier Cancer Center
Public Affairs Director, EURORDIS-Rare Diseases Europe
Director, Global Access Strategy, DMD Gene Therapy, Pfizer
Consulting Physician, Association of Austrian Social Insurance Institutions
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence